Ethema Health Corporation carries a market capitalization of 772,628.00, placing it among publicly traded companies globally. Its enterprise value stands at 20.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 772,628.00 |
| Enterprise Value | 20.46M |
Ethema Health Corporation currently has 7.73B shares outstanding.
| Shares Outstanding | 7.73B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Ethema Health Corporation trades at a trailing price-to-earnings ratio of 3.24. The price-to-sales ratio is 0.57, and the price-to-book ratio stands at 0.10.
| PE Ratio | 3.24 |
| PS Ratio | 0.57 |
| PB Ratio | 0.10 |
| P/TBV Ratio | -0.43 |
| P/FCF Ratio | -22.01 |
| P/OCF Ratio | -7.51 |
| EV / Sales | 3.40 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 24.77 |
Ethema Health Corporation maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -231.14, indicating conservative leverage, while an interest coverage ratio of -0.73 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.05 |
| Quick Ratio | 0.05 |
| Debt / Equity | -231.14 |
| Debt / EBITDA | -23.98 |
| Interest Coverage | -0.73 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -17.44 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Ethema Health Corporation's stock has declined approximately -66.66667% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -66.66667% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Ethema Health Corporation generated 6.02M in revenue and converted that into -2.06M in net income, yielding earnings per share of 0.00. EBITDA reached -718,790.00, while operating income came in at -1.33M.
| Revenue | 6.02M |
| Gross Profit | N/A |
| Operating Income | -1.33M |
| Pretax Income | -2.17M |
| Net Income | -2.06M |
| EBITDA | -718,790.00 |
| EBIT | -1.33M |
| Earnings Per Share (EPS) | 0.00 |
Ethema Health Corporation holds 244,771.00 in cash and equivalents against 17.24M in total debt, resulting in a net debt position of 6.73M. Total book value stands at 32.87M, with working capital of -9.13M providing operational flexibility.
| Cash & Cash Equivalents | 244,771.00 |
| Total Debt | 17.24M |
| Net Debt | 6.73M |
| Equity (Book Value) | 32.87M |
| Book Value Per Share | 0.01 |
| Working Capital | -9.13M |
Ethema Health Corporation produced -455,704.00 in operating cash flow over the past twelve months. After subtracting -300,259.00 in capital expenditures, free cash flow totaled -755,963.00 - equivalent to 0.00 per share.
| Operating Cash Flow | -455,704.00 |
| Capital Expenditures | -300,259.00 |
| Free Cash Flow | -755,963.00 |
| FCF Per Share | 0.00 |
Ethema Health Corporation operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -22.16 and net profit margin of -34.30 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -22.16 |
| Pretax Margin | -36.00 |
| Profit Margin | -34.30 |
| EBITDA Margin | -11.95 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -48.97 |
| FCF Yield | -4.54 |
Ethema Health Corporation posts an Altman Z-Score of -6.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.05 |